AI assistant
IRIDEX CORP — Director's Dealing 2015
Mar 17, 2015
34978_dirs_2015-03-16_b74eb4b1-f2c3-40ea-a9f8-dd694a0cdb09.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2015-02-27
Reporting Person: MOORE WILLIAM M (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-27 | Common Stock | M | 190000 | — | Acquired | 342396 | Direct |
| 2015-03-13 | Common stock | F | 61465 | $9.08 | Disposed | 280931 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-27 | Performance Rights | $ | M | 190000 | Disposed | 2015-02-27 | Common Stock (190000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 78944 | Indirect |
Footnotes
F1: Represents shares of Common stock issued upon the vesting of performance rights granted on March 25, 2013.
F2: The RSU's convert into the Issuer's Common Stock on a one-for-one basis.
F3: The performance right represents a contingent right to receive up to 220,000 shares of IRIDEX common stock. The number of shares issuable pursuant to the performance right was determined on February 27, 2015 based upon the Company's average stock price performance of fair market value, as set forth within a Restricted Stock Unit Award Agreement between IRIDEX and the reporting person.